We are live on ! Find out more
WINT

Windtree Therapeutics Inc

Delisted

WINT was delisted on the 4th of May, 2017.

60 hedge funds and large institutions have $117M invested in Windtree Therapeutics Inc in 2013 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 5

136% more capital invested

Capital invested by funds: $49.7M → $117M (+$67.4M)

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

20% more funds holding

Funds holding: 5060 (+10)

16% more call options, than puts

Call options by funds: $425K | Put options by funds: $366K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
60
Holders Change
+10
Holders Change %
+20%
% of All Funds
1.74%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
15
Increased
23
Reduced
10
Closed
5
Calls
$425K
Puts
$366K
Net Calls
+$59K
Net Calls Change
+$159K

WINT Hedge Fund Activity: Q4 2013 in Review

60 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q4 2013, worth a combined $117M — up 136% from $49.7M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new WINT positions and 5 closed out — a net gain of 10 holders — while 23 added to existing stakes and 10 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $13.2M. The largest seller was Wells Fargo, cutting an estimated $797K.

  • 60 institutional investors held Windtree Therapeutics Inc (WINT) as of Q4 2013, up from 50 in Q3 2013.
  • Funds reported $117M of Windtree Therapeutics Inc stock for Q4 2013, up 136% quarter-over-quarter.
  • 15 funds opened new Windtree Therapeutics Inc positions in Q4 2013 and 5 closed out, a net change of +10 holders.
  • The largest Windtree Therapeutics Inc buyer in Q4 2013 was Broadfin Capital, an estimated $13.2M added.
  • The largest Windtree Therapeutics Inc seller in Q4 2013 was Wells Fargo, an estimated $797K sold.

Based on aggregated 13F filings for Q4 2013.